Table 2.

Patients’ Postsurgical Status, Relative to Transient and Permanent Changes, and Information About Tumor Recurrence and Post-Surgery Treatments. Each Patient Can Have One, or a Combination of These Factors

Parameters	No. of Cases (% value)
Transient deficits
Total cases	77/263 (32.63%)
Mild language deficits	42 (15.73%)
SMA syndrome	13 (4.94%)
Motor deficits	7 (2.66%) (2 severe motor deficit 0/5, 5 mild motor deficits 4/5)
Visual field deficits	4 (1.52%) (2 homonymous hemianopsia, 2 superior quadrantopsy)
Facial drop	4 (1.52%)
Spatial neglect syndrome	3 (1.14%)
Upper limb coordination deficits	2 (0.76%)
Decrease in psycho-motor speed	1 (0.38%)
Gerstman’s syndrome	1 (0.38%)
Permanent deficits
Total cases	8/259 (3.08%)
Mild dysarthria	2 (0.78%)
Facial weakness	1 (0.39%)
Hemiparesis (3/5)	2 (0.78%)
Mild hyposthenia	1 (0.39%)
Upper quadrantanopsy	2 (0.78%)
Treatment at tumor recurrence
Second surgery	70/267 (26.22%)
Chemotherapy	32/267 (11.98%)
Chemo and radio	6/267 (2.2%)
Histological diagnosis at second surgery
WHO grade II	47/70 (67.15%)
WHO grade III	9/70 (12.85%)
WHO grade IV	7/70 (10%)
NA	7/70 (10%)
Treatment after second surgery
None	26 (37.14%)
CT	11 (15.71%)
RT	2 (2.86%)
CT + RT	27 (38.57%)
NA	4 (5.72%)
Time between first and second surgery Months	66.71 (9-215) 5.5 yr

Abbreviations: CT, chemotherapy; NA, not applicable; RT, radiotherapy; SMA, supplementary motor area.